跳到正文
原文
Medical Xpress·· 2026-10-03AI 评分46

研究团队重新审视母体血中胎儿游离DNA,以改善无创产前检测准确性

Tracing fetal DNA through maternal blood can help reduce prenatal testing errors

AI 导读

由阿德莱德大学牵头的国际团队在Science Advances上发表综述,重新审视了母体血中胎儿游离DNA的来源、运输及关联结构,旨在提高无创产前检测的准确率。该研究聚焦于提升检测中的胎儿DNA比例(fetal fraction),认为这有助于减少非侵入性产前检测中约47%的高危假阳性误报,并有望在未来实现更广泛遗传病筛查及妊娠并发症的早期识别。

正文
pregnant woman with doctor
Credit: Unsplash/CC0 Public Domain

Understanding how fetal DNA travels in a pregnant woman's blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances.

An international team of scientists, led by Adelaide University, has reviewed decades of research to better understand where fetal DNA comes from, how it enters the bloodstream and what structures it may be associated with once it is circulating in maternal blood.

The researchers challenge long-held assumptions about fetal DNA, work that could help improve the accuracy of noninvasive prenatal testing (NIPT).

NIPT is a widely used blood test that screens for genetic conditions during pregnancy, analyzing small fragments of DNA from the placenta that circulate in the mother's bloodstream.

Since its introduction in 2011, millions of women around the world have used NIPT because it offers a safer alternative to invasive procedures such as amniocentesis.

In Australia, around 30% of families opt to pay 500 Australian dollars for the test—often out of pocket.

False alarms still require invasive confirmation

Despite its success and popularity, NIPT still has limitations, according to lead author Kieran Sparkes, an Adelaide University doctoral candidate from the Future Industries Institute.

"For most parents, a negative NIPT result provides reassurance about the health of their unborn baby. However, if NIPT does indicate a high risk for a chromosomal condition, parents have to wait over a month for confirmation and undergo an invasive diagnostic procedure," Sparkes said.

"High-risk NIPT results are rare, but in 47% of cases, a high-risk result turns out to be a false alarm, creating unnecessary stress as well as an unnecessary surgical operation.

"If we can better understand how fetal DNA is packaged and transported, we may be able to develop new ways to enrich and isolate it. That could improve test accuracy, reduce false results and potentially allow screening for a much broader range of genetic conditions."

DNA packaging could improve screening

The researchers found that while fetal DNA is generally believed to originate from the placenta, key questions remain unanswered about the exact cell types that release it and whether the DNA travels attached to biological particles such as extracellular vesicles or other molecular structures.

According to the authors, answering these questions could help scientists increase the proportion of fetal DNA available for testing, known as the "fetal fraction," which is one of the biggest challenges facing current prenatal screening technologies.

"Science and technology have advanced rapidly, but our biological understanding of fetal DNA has not kept pace," said professor Benjamin Thierry, director of the Precision Nanomedicine Program at Adelaide University.

"By uncovering the fundamental biology of fetal DNA, we can create new tools that make prenatal testing more reliable, more comprehensive and potentially more affordable."

The researchers believe that future advances could also allow prenatal tests to detect a wider range of genetic disorders from a simple blood sample and may even help identify pregnancy complications such as preeclampsia earlier.

The team says further research into the origins and structure of fetal DNA is now a critical priority if the full potential of prenatal genetic testing is to be realized.

Publication details

Kieran Sparkes et al, Reappraising the topology of cell-free fetal DNA in maternal blood towards improved prenatal genetic diagnostics, Science Advances (2026). DOI: 10.1126/sciadv.aef5425. www.science.org/doi/10.1126/sciadv.aef5425

Journal information: Science Advances

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Tracing fetal DNA through maternal blood can help reduce prenatal testing errors (2026, October 2) retrieved 2 October 2026 from https://medicalxpress.com/news/2026-10-fetal-dna-maternal-blood-prenatal.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com